Loading chart…
PRE-MARKET
Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, and South America. The company manufactures APIs and bulk drugs, such as antifungals, anaethetics, immuno suppressants, anginotensin receptor blocker, and intermediates for antifungals. It also manufactures lyophilized injections for antibiotic, antifungal, cardiac medications, infertility treatments, antiviral solutions, and proton pump inhibitors (PPIs) segments.
Gufic Biosciences Limited (GUFICBIO) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The GUFICBIO share price is ₹474.35 (+10.22% today), with a market capitalisation of ₹48B and a price-to-earnings (P/E) ratio of 65.7. MarketRipple tracks the GUFICBIO investment thesis, the ripple-chain impact of market events on Gufic Biosciences Limited, and the Healthcare sector outlook.
Open
₹439.90
High
₹480.95
Low
₹436.40
Prev. Close
₹430.35
52W High
₹480.95
52W Low
₹268.00
Day range
₹436.40–₹480.95
52-week range
₹268.00–₹480.95
Volume
761K
P/E
65.7
ROE
9.7%
D/E
0.61
Margin
7.5%
Gufic Biosciences Limited (NSE: GUFICBIO) is currently trading at ₹474.35 (+10.22%).
Gufic Biosciences Limited's market capitalization is ₹48B.
Gufic Biosciences Limited's price-to-earnings (P/E) ratio is 65.7.
Gufic Biosciences Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).